According to John Miller, executive director, MidAtlantic Business Group on Health, The National Business Coalition on Health (NBCH) is an organization that seeks to drive conversations about prescription drug benefit management (PBM) to value.
According to John Miller, executive director, MidAtlantic Business Group on Health, The National Business Coalition on Health (NBCH) is an organization that seeks to drive conversations about prescription drug benefit management (PBM) to value. Utilizing an evidence-based, comprehensive assessment called ValuePort, NBCH helps employers consider the value PBMs provide in quality (rather than cost alone).
The members and coalitions in NBCH aim to develop programs that underline their 4 pillars of value-based purchasing. Those four pillars include: “standardizing performance measurement, reporting performance measurement results publicly, reforming the health care delivery payment system, and engaging consumers in informed decision making.”
NBCH’s assessment, a subset of their other program eValue8, promotes quality and transparency by incorporating services such as URAC and NCQA accreditations into its measurements. eValue8 is NBCH’s “flagship” vendor management tool that is used by employers to measure vendor performance. Valueport builds on eValue8’s offerings by including performance comparisons and rankings, as well as raising plan sponsor expectations. It is hoped that these quality measures will help providers and vendors to better understand data and to implement strategies that will improve health outcomes.
Miller suggests that their assessment focuses on population health, cultural competencies such as ethnicity and geography, and patient engagement. While not a consumer-based service, Miller says it’s important for stakeholders to get involved with “wise decision making” as close to the consumer as possible. This is especially true for management of conditions such as diabetes and obesity.
Coalitions who participated in a pilot program of ValuePort found that there were opportunities for more meaningful engagement with employers, access to training and skill development of useful data analysis, and an ability to observe other coalitions’ best practices and approaches to value-based purchasing.
The ValuePort assessment will be used by the NBCH’s 60 coalitions and will reach approximately 7,000 employers. Miller suggests that other PBMs can benefit in collaborating with employers.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More